Splice Bio

Barcelona, Spain

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

$135.0M raised

Jun 2025

Series B

Top Investors

New Enterprise AssociatesEQT Life SciencesYsios CapitalAsabys PartnersGilde Healthcare

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Splice Bio raised?

Splice Bio has raised $135.0M in total funding. The most recent round was Series B. The last funding was announced in June 2025.

Who are Splice Bio's investors?

Splice Bio's investors include New Enterprise Associates, EQT Life Sciences, Ysios Capital, Asabys Partners, Gilde Healthcare.

Where is Splice Bio headquartered?

Splice Bio is headquartered in Barcelona, Spain.

What does Splice Bio do?

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

What stage is Splice Bio at?

Splice Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 11, 2025.

MLA

"Splice Bio — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/splice-bio. Accessed June 3, 2026.

APA

VCBacked. (2025). Splice Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/splice-bio

Wikipedia (cite web)

{{cite web |title=Splice Bio — Funding & Investors |url=https://www.vcbacked.co/company/splice-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 11, 2025.